BACKGROUND: Cell and molecular mechanisms mediating the cardiovascular effects of alcohol are not fully understood. Our aim was to determine the effect of moderate ethanol (EtOH) on sonic hedgehog (SHh) signaling in regulating possible stem cell antigen-1 positive (Sca1+ ) progenitor stem cell involvement during pathologic arterial remodeling. METHODS: Partial ligation or sham operation of the left carotid artery was performed in transgenic Sca1-enhanced green fluorescent protein (eGFP) mice gavaged with or without "daily moderate" EtOH. RESULTS: The EtOH group had reduced adventitial thickening and less neointimal formation, compared to ligated controls. There was expansion of eGFP-expressing (i.e., Sca1+ ) cells in remodeled vessels postligation (day 14), especially in the neo intima. EtOH treatment reduced the number of Sca1+ cells in ligated vessel cross-sections concomitant with diminished remodeling, compared to control ligated vessels. Moreover, EtOH attenuated SHh signaling in injured carotids as determined by immunohistochemical analysis of the target genes patched 1 and Gli2, and RT-PCR of whole-vessel Gli2 mRNA levels. Intraperitoneal injection of ligated Sca1-eGFP mice with the SHh signaling inhibitor cyclopamine diminished SHh target gene expression, reduced the number of Sca1+ cells, and ameliorated carotid remodeling. EtOH treatment of purified Sca1+ adventitial progenitor stem cells in vitro inhibited SHh signaling, and their rSHh-induced differentiation to vascular smooth muscle cells. CONCLUSIONS: EtOH reduces SHh-responsive Sca1+ progenitor cell myogenic differentiation/expansion in vitro and during arterial remodeling in response to ligation injury in vivo. Regulation of vascular Sca1+ progenitor cells in this way may be an important novel mechanism contributing to alcohol's cardiovascular protective effects.
BACKGROUND: Cell and molecular mechanisms mediating the cardiovascular effects of alcohol are not fully understood. Our aim was to determine the effect of moderate ethanol (EtOH) on sonic hedgehog (SHh) signaling in regulating possible stem cell antigen-1 positive (Sca1+ ) progenitor stem cell involvement during pathologic arterial remodeling. METHODS: Partial ligation or sham operation of the left carotid artery was performed in transgenicSca1-enhanced green fluorescent protein (eGFP) mice gavaged with or without "daily moderate" EtOH. RESULTS: The EtOH group had reduced adventitial thickening and less neointimal formation, compared to ligated controls. There was expansion of eGFP-expressing (i.e., Sca1+ ) cells in remodeled vessels postligation (day 14), especially in the neo intima. EtOH treatment reduced the number of Sca1+ cells in ligated vessel cross-sections concomitant with diminished remodeling, compared to control ligated vessels. Moreover, EtOH attenuated SHh signaling in injured carotids as determined by immunohistochemical analysis of the target genes patched 1 and Gli2, and RT-PCR of whole-vessel Gli2 mRNA levels. Intraperitoneal injection of ligated Sca1-eGFP mice with the SHh signaling inhibitor cyclopamine diminished SHh target gene expression, reduced the number of Sca1+ cells, and ameliorated carotid remodeling. EtOH treatment of purified Sca1+ adventitial progenitor stem cells in vitro inhibited SHh signaling, and their rSHh-induced differentiation to vascular smooth muscle cells. CONCLUSIONS:EtOH reduces SHh-responsive Sca1+ progenitor cell myogenic differentiation/expansion in vitro and during arterial remodeling in response to ligation injury in vivo. Regulation of vascular Sca1+ progenitor cells in this way may be an important novel mechanism contributing to alcohol's cardiovascular protective effects.
Authors: Anh T Nguyen; Delphine Gomez; Robert D Bell; Julie H Campbell; Alexander W Clowes; Giulio Gabbiani; Cecilia M Giachelli; Michael S Parmacek; Elaine W Raines; Nancy J Rusch; Mei Y Speer; Michael Sturek; Johan Thyberg; Dwight A Towler; Mary C Weiser-Evans; Chen Yan; Joseph M Miano; Gary K Owens Journal: Circ Res Date: 2012-10-23 Impact factor: 17.367
Authors: Jean-Bernard Ruidavets; Pierre Ducimetière; Alun Evans; Michèle Montaye; Bernadette Haas; Annie Bingham; John Yarnell; Philippe Amouyel; Dominique Arveiler; Frank Kee; Vanina Bongard; Jean Ferrières Journal: BMJ Date: 2010-11-23
Authors: Ciaran J Mooney; Roya Hakimjavadi; Emma Fitzpatrick; Eimear Kennedy; Dermot Walls; David Morrow; Eileen M Redmond; Paul A Cahill Journal: Stem Cells Int Date: 2015-05-06 Impact factor: 5.443
Authors: Naresh K Rajendran; Weimin Liu; Charles C Chu; Paul A Cahill; Eileen M Redmond Journal: Alcohol Clin Exp Res Date: 2021-09-29 Impact factor: 3.455
Authors: Mariana Di Luca; Emma Fitzpatrick; Denise Burtenshaw; Weimin Liu; Jay-Christian Helt; Roya Hakimjavadi; Eoin Corcoran; Yusof Gusti; Daniel Sheridan; Susan Harman; Catriona Lally; Eileen M Redmond; Paul A Cahill Journal: NPJ Regen Med Date: 2021-03-01
Authors: Deborah Toledo-Flores; Anna Williamson; Nisha Schwarz; Sanuja Fernando; Catherine Dimasi; Tyra A Witt; Thao M Nguyen; Amrutesh S Puranik; Colin D Chue; Sinny Delacroix; Daniel B Spoon; Claudine S Bonder; Christina A Bursill; Belinda A Di Bartolo; Stephen J Nicholls; Robert D Simari; Peter J Psaltis Journal: Sci Rep Date: 2019-05-13 Impact factor: 4.379
Authors: Claire Molony; Damien King; Mariana Di Luca; Michael Kitching; Abidemi Olayinka; Roya Hakimjavadi; Lourdes A N Julius; Emma Fitzpatrick; Yusof Gusti; Denise Burtenshaw; Killian Healy; Emma K Finlay; David Kernan; Andreu Llobera; Weimin Liu; David Morrow; Eileen M Redmond; Jens Ducrée; Paul A Cahill Journal: Stem Cell Rev Rep Date: 2021-03-17 Impact factor: 5.739